Careers  |  Sign In  |  Register  |   Twitter

Latest in Women’s Health

Each week we present the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing updates in the fields of medicine and healthcare.
A new FDA regulated device from Nuvo Group is being utilized to monitor pregnant women and their babies, according to a report from Reuters. Nuvo Group’s product, to be launched as Ritmo Beats at the end of 2015, utilizes an algorithm that monitors and detects the mother’s and the fetus’s heartbeat...
According to Reuters, Ibrance, a breast cancer drug from Pfizer is currently in Phase III clinical trials of a new drug. The drug is designed to treat the most common type of breast cancer, estrogen-receptor positive, human epidermal growth factor receptor 2-negative. Ibrance has been shown to increase the...